Quick Answer
Anixa Biosciences Inc reported Total Revenue of $210.0 thousand for the year ending 2023.
- Anixa Biosciences Inc showed a decrease of -59.0% in Total Revenue from 2021 to 2023.
- This data is from Anixa Biosciences Inc's annual report (Form 10-K), filed with the SEC on January 10, 2025.
- XBRL data for this metric is available from 2016 to 2023 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2016: $100.0 thousand | Q3 2017: $362.5 thousand | Q2 2018: $750.0 thousand | Q3 2018: $362.5 thousand | Q2 2019: $250.0 thousand | Q1 2021: $513.0 thousand | Q2 2023: $210.0 thousand.
- Over the full 7 years of available data (2016 to 2023), Anixa Biosciences Inc's Total Revenue has declined by 30.0%.
- Historical annual values: Fiscal year 2023: $210.0 thousand | Fiscal year 2021: $512.0 thousand | Fiscal year 2019: $250.0 thousand | Fiscal year 2019: $250.0 thousand | Fiscal year 2018: $1.11 million | Fiscal year 2017: $362.5 thousand | Fiscal year 2016: $300.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: